BAY86-6150

BAY86-6150 · Bayer

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BAY86-6150, covering 2014-08-21 to 2015-07-01. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2/ 3 Trial to Evaluate the Efficacy and Safety of BAY86-6150 [Phase 2, Phase 3]